BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4009946)

  • 1. [Study on the transfer of cefroxadine to human tears].
    Hara J; Tanaka Y; Harino S; Deguchi K
    Jpn J Antibiot; 1985 Feb; 38(2):230-4. PubMed ID: 4009946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefroxadine (CGP-9000), an orally active cephalosporin.
    Yasuda K; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):105-10. PubMed ID: 6998373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative double-blind study of cefroxadine and cephalexin in the treatment of complicated urinary tract infection].
    Kamidono S; Harada M; Ishigami J; Takasaki N; Miyazaki S; Furusawa T; Mizunoe Y; Ito K; Momose S; Nakamuta S
    Jpn J Antibiot; 1983 Sep; 36(9):2571-94. PubMed ID: 6361324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of oral cephalosporins: cephradine cephalexin.
    Finkelstein E; Quintiliani R; Lee R; Bracci A; Nightingale CH
    J Pharm Sci; 1978 Oct; 67(10):1447-50. PubMed ID: 702300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Double-blind comparative trial of cefroxadine and cephalexin in the treatment of acute suppurative otitis media and acute exacerbation of chronic suppurative otitis media].
    Baba S; Murai K; Kinoshita H; Kawai T; Koyama K; Tsukiyama M; Maruo T; Wada K; Inagaki M; Matsushita T
    Jpn J Antibiot; 1983 Sep; 36(9):2595-634. PubMed ID: 6361325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect and transfer into the wound exudate of cefroxadine used in the treatment of soft tissue infection].
    Takata N; Yamada T; Kubota T; Kaneko T
    Jpn J Antibiot; 1983 Sep; 36(9):2529-34. PubMed ID: 6655867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model.
    Schneider P; Tosch W; Maurer M; Zak O
    J Antibiot (Tokyo); 1982 Jul; 35(7):843-9. PubMed ID: 7174537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of high-dose oral cephalosporins.
    Chow M; Quintiliani R; Cunha BA; Thompson M; Finkelstein E; Nightingale CH
    J Clin Pharmacol; 1979 Apr; 19(4):185-94. PubMed ID: 438352
    [No Abstract]   [Full Text] [Related]  

  • 9. [A contribution on the pharmacokinetics of oral cephalosporin antibiotics (author's transl)].
    Dvorácek K; Modr Z; Krebs V
    Cas Lek Cesk; 1976 May; 115(20-21):622-7. PubMed ID: 1277248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of cefroxadine in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Inokuma K; Nakamura H
    Jpn J Antibiot; 1981 Dec; 34(12):1663-79. PubMed ID: 7334591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of cefroxadine dry syrup in pediatric field (author's transl)].
    Minamitani M; Hachimori K; Suzuki M; Minamikawa I
    Jpn J Antibiot; 1981 Dec; 34(12):1626-33. PubMed ID: 7334587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of cephalexin and cephradine distribution in the body of rats].
    Klimova VS
    Antibiotiki; 1979 Oct; 24(10):764-7. PubMed ID: 496419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral cephalosporins.
    Finkelstein ER; Quintiliani R; Nightingale CH
    J Pediatr; 1978 Nov; 93(5):902. PubMed ID: 712517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Laboratory and clinical studies on cefroxadine (author's transl)].
    Nishikawa K; Aso K; Miyachi Y; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1981 Dec; 34(12):1647-54. PubMed ID: 7334589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
    Cho N; Araki H; Ishikawa T; Kunii K; Fukunaga K; Deguchi K
    Jpn J Antibiot; 1983 Sep; 36(9):2535-48. PubMed ID: 6655868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of cefroxadine in the field of obstetrics and gynecology].
    Uchida S; Hayashi H; Tominaga M; Kohno K; Matsunaga M; Kudo S; Kawamura R
    Jpn J Antibiot; 1983 Sep; 36(9):2549-55. PubMed ID: 6655869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials of cefroxadine on skin and soft tissue infections in the field of pediatrics (author's transl)].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Nishiyama T; Fujimoto T; Nakajima T; Ishimoto K; Tominaga K; Yamashita F; Tomoishi T; Takenaka S; Kamezaki K; Ohyama K; Takasaki K; Oki S; Yoshinaga Y; Nagai T; Kawano N; Toyoda J; Shimohida T
    Jpn J Antibiot; 1981 Dec; 34(12):1732-46. PubMed ID: 7038190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of cephalexin and cephradine in surgical patients].
    Iakovlev VP; Marshak AM; Klimova VS; Lur'e LA
    Antibiotiki; 1977 Aug; 22(8):739-42. PubMed ID: 334053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.
    Lecaillon JB; Hirtz JL; Schoeller JP; Humbert G; Vischer W
    Antimicrob Agents Chemother; 1980 Nov; 18(5):656-60. PubMed ID: 7447423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of cefroxadine in bacterial infections of the eye].
    Ooishi M; Nagai S; Nishizuka K; Tanaka R; Takagi K; Hara J; Tanaka Y; Ichihashi K; Hirose Y; Akashi N
    Jpn J Antibiot; 1983 Sep; 36(9):2635-64. PubMed ID: 6655872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.